- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
€2417EUR$2,500USD£2,076GBP
- Report
- August 2021
- 401 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- August 2022
- 167 Pages
Global
From €9185EUR$9,500USD£7,889GBP
- Report
- August 2022
- 83 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- July 2022
- 184 Pages
Global
From €9185EUR$9,500USD£7,889GBP
- Report
- July 2022
- 92 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- January 2022
- 200 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,280GBP
- Report
- August 2022
Global
From €764EUR$790USD£656GBP
- Drug Pipelines
- July 2020
- 112 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- May 2022
- 57 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Drug Pipelines
- March 2021
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- February 2024
- 189 Pages
Global
From €3480EUR$3,600USD£2,990GBP
The Warts Drug market is a subset of the Dermatological Drugs market, which includes products used to treat skin conditions. Warts Drugs are used to treat warts, which are caused by the human papillomavirus (HPV). These drugs are typically topical medications, such as creams, gels, and ointments, that are applied directly to the affected area. They may also be administered orally or injected. Common active ingredients in Warts Drugs include salicylic acid, podophyllin, and imiquimod.
The Warts Drug market is highly competitive, with many companies offering products for the treatment of warts. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. Other companies include Bayer, Mylan, and Sun Pharmaceuticals. Show Less Read more
